India is among the top 12 global destinations and 3rd in the Asia-Pacific region in Biotechnology R&D.
100%
FDI through automatic route for new projects.
No.1
producer of recombinant Hepatitis B vaccine.
2nd
highest number of USFDA-approved plants outside the US.
No.1
producer of BT cotton variety in the world.
US$150bn
projected value of biotech sector by 2025 with 30.5% CAGR.
Leading
destination for clinical trials, contract research, and manufacturing.
+500
USFDA approved pharma plants in India; 2nd largest outside of USA.
800
biotechnology companies in India, driving global partnerships.
50
bio-incubators and 9 biotech parks, with new ones in the pipeline.
dstsec@nic.in
+91-11-26567373, 26962819
birac.dbt@nic.in
+ 91-11-24389600
sk@csir.res.in
011-23710618
anju_bhalla@nic.in
+91-11-26562122/25/33/44,
+91-11-26511439, 26510068, 23386051
India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive and capital establishments
Abbot Laboratories - American health care company
Sanofi Aventis - providers of diabetes drugs and vaccines
Endo Pharmaceuticals - Generics and speciality manufacturer
GE Healthcare - Medical equipment & diagnostic products
Bosch - Healthcare and medical technology manufacturer
Helix - Planning and design of healthcare facilities
BPI - IT solutions for business requirements in life sciences
Tekes - Financing research, development and innovation
India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive, and capital establishments